Safety and efficacy of a generic fixed-dose combination of stavudine, lamivudine and nevirapine antiretroviral therapy between HIV-infected patients with baseline CD4 <50 versus CD...

by Likanonsakul Sirirat, Chimsuntorn Sukanya, Manosuthi Weerawat, Sungkanuparph Somnuek
Published 2007-03-01

Durability of Stavudine, Lamivudine and Nevirapine among Advanced HIV-1 Infected Patients with/without Prior Co-administration of Rifampicin: A 144-week Prospective Study

by Prasithisirikul Wisit, Tantanathip Preecha, Manosuthi Weerawat, Likanonsakul Sirirat, Sungkanuparph Somnuek
Published 2008-10-01

<it>HLA-Cw*04 </it>allele associated with nevirapine-induced rash in HIV-infected Thai patients

by Tunthanathip Preecha, Prasithsirikul Wisit, Uttayamakul Sumonmal, Feangvad Siriluk, Rattanatham Tippawan, Likanonsakul Sirirat, Nakayama Emi E, Shioda Tatsuo
Published 2009-10-01

Effects of <it>CYP2B6 </it>G516T polymorphisms on plasma efavirenz and nevirapine levels when co-administered with rifampicin in HIV/TB co-infected Thai adults

by Kalambaheti Thareerat, Wichukchinda Nuanjun, Manosuthi Weerawat, Likanonsakul Sirirat, Uttayamakul Sumonmal, Nakayama Emi E, Shioda Tatsuo, Khusmith Srisin
Published 2010-03-01

Viral hepatitis and HIV-associated tuberculosis: Risk factors and TB treatment outcomes in Thailand

by Likanonsakul Sirirat, Akksilp Somsak, Nateniyom Sriprapa, Srisuwanvilai La-ong, Luanloed Phinai, Charusuntonsri Pricha, Pinjeesekikul Duangporn, Kittikraisak Wanitchaya, Sirinak Chawin, Sattayawuthipong Wanchai, Burapat Channawong, Varma Jay K
Published 2008-07-01